Risk of Parkinson’s disease in patients with schizophrenia: Impact of antipsychotic medication use

Jin Yeon Gil, Kyung Hyun Min, Jun Hyeob Kim, Jun Hyuk Park, Ji Min Han, Kyung Eun Lee · 2026

Read Risk of Parkinson’s disease in patients with schizophrenia: Impact of antipsychotic medication use by Jin Yeon Gil, Kyung Hyun Min, Jun Hyeob Kim, Jun Hyuk Park, Ji Min Han, Kyung Eun Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0346233.txt.

Description

Jin Yeon Gil and her team used health data from South Korea to ask a hard question. Do people with schizophrenia face a higher risk of Parkinson's in later life? Both ills touch the same brain chemical. The team matched patients with like peers and weighed drugs and other ills.

The risk came out near three times as high. One drug, risperidone, pushed the risk up more. A second drug, quetiapine, pulled it down. Head wounds and stroke added their own risk. The team urges doctors to watch for stiff, slow moves in these patients. They also call for more work on drug choice.

Catalog record

CREATORJin Yeon Gil, Kyung Hyun Min, Jun Hyeob Kim, Jun Hyuk Park, Ji Min Han, Kyung Eun Lee
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36515
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0346233

Browse the full library · About the Tower of Babel